| Quarter | Filling ID |
|---|---|
| Q4 25 | 0002002654-26-000001 |
| Q3 25 | 0002002654-25-000006 |
| Q2 25 | 0002002654-25-000004 |
| Q1 25 | 0002002654-25-000003 |
| Q4 24 | 0002002654-25-000001 |
| Q3 24 | 0002002654-24-000005 |
| Q2 24 | 0002002654-24-000004 |
| Q1 24 | 0002002654-24-000002 |
| Q4 23 | 0002002654-24-000001 |
| Q3 23 | 0002002654-23-000008 |
| Q2 23 | 0002002654-23-000007 |
| Q1 23 | 0002002654-23-000006 |
| Q4 22 | 0002002654-23-000005 |
| Q3 22 | 0002002654-23-000004 |
| Q2 22 | 0002002654-23-000003 |
| Q1 22 | 0002002654-23-000002 |
| Q4 21 | 0002002654-23-000001 |
| Name | Title | CUSIP | Ticker | Value | Shares | Share Price | Investment | % of Portfolio |
|---|---|---|---|---|---|---|---|---|
| Seagen Inc. | COM | 81181C104 | $8,278,767 | 47,269,424 | SOLE | |||
| BeiGene, Ltd. | SPONSORED ADR | 07725L102 | $3,015,126 | 11,668,897 | SOLE | |||
| Incyte Corporation | COM | 45337C102 | $2,783,337 | 31,999,741 | SOLE | |||
| ACADIA Pharmaceuticals Inc. | COM | 4225108 | $2,240,219 | 41,904,586 | SOLE | |||
| Kodiak Sciences Inc. | COM | 50015M109 | $2,039,104 | 13,879,952 | SOLE | |||
| Alexion Pharmaceuticals, Inc. | COM | 15351109 | $1,368,786 | 8,760,794 | SOLE | |||
| Prelude Therapeutics Incorporated | COM | 74065P101 | $723,988 | 10,118,636 | SOLE | |||
| BioMarin Pharmaceutical Inc. | COM | 09061G101 | $665,505 | 7,589,294 | SOLE | |||
| Invitae Corporation | COM | 46185L103 | $654,292 | 15,649,182 | SOLE | |||
| Ascendis Pharma A/S | SPONSORED ADR | 04351P101 | $590,446 | 3,540,270 | SOLE | |||
| AbCellera Biologics Inc. | COM | 00288U106 | $420,515 | 10,450,180 | SOLE | |||
| Mirati Therapeutics, Inc. | COM | 60468T105 | $309,645 | 1,409,784 | SOLE | |||
| argenx SE | SPONSORED ADR | 04016X101 | $299,842 | 1,019,557 | SOLE | |||
| IGM Biosciences, Inc. | COM | 449585108 | $277,663 | 3,144,892 | SOLE | |||
| Madrigal Pharmaceuticals, Inc. | COM | 558868105 | $166,668 | 1,499,213 | SOLE | |||
| Amarin Corporation plc | SPONSORED ADR | 23111206 | $136,880 | 27,991,761 | SOLE | |||
| Heron Therapeutics, Inc. | COM | 427746102 | $126,878 | 5,994,704 | SOLE | |||
| Kymera Therapeutics, Inc. | COM | 501575104 | $121,471 | 1,959,211 | SOLE | |||
| Allakos Inc. | COM | 01671P100 | $99,995 | 714,250 | SOLE | |||
| Cerus Corporation | COM | 157085101 | $94,895 | 13,713,195 | SOLE | |||
| BioCryst Pharmaceuticals, Inc. | COM | 09058V103 | $94,584 | 12,695,818 | SOLE | |||
| Pacific Biosciences of California, Inc. | COM | 69404D108 | $83,059 | 3,201,972 | SOLE | |||
| Zymeworks Inc. | COM | 98985W102 | $80,742 | 1,708,472 | SOLE | |||
| Insmed Incorporated | COM PAR $.01 | 457669307 | $71,773 | 2,156,001 | SOLE | |||
| Forma Therapeutics Holdings, Inc. | SHS | 34633R104 | $70,668 | 2,024,876 | SOLE | |||
| Rhythm Pharmaceuticals, Inc. | COM | 76243J105 | $68,821 | 2,314,873 | SOLE | |||
| Neurocrine Biosciences, Inc. | COM | 64125C109 | $64,888 | 676,975 | SOLE | |||
| Axsome Therapeutics, Inc. | COM | 05464T104 | $63,452 | 778,834 | SOLE | |||
| Ultragenyx Pharmaceutical Inc. | COM | 90400D108 | $61,524 | 444,444 | SOLE | |||
| Nurix Therapeutics, Inc. | COM | 67080M103 | $58,820 | 1,788,921 | SOLE | |||
| Atreca, Inc. | CL A COM | 04965G109 | $57,054 | 3,532,760 | SOLE | |||
| Neoleukin Therapeutics, Inc. | COM | 64049K104 | $53,887 | 3,821,740 | SOLE | |||
| Adaptimmune Therapeutics plc | SPONSORED ADR | 00653A107 | $52,988 | 9,830,877 | SOLE | |||
| Apellis Pharmaceuticals, Inc. | COM | 03753U106 | $51,283 | 896,551 | SOLE | |||
| Kiniksa Pharmaceuticals, Ltd. | COM CL A | G5269C101 | $49,469 | 2,799,577 | SOLE | |||
| ADC Therapeutics SA | SHS | H0036K147 | $45,394 | 1,418,107 | SOLE | |||
| Aligos Therapeutics, Inc. | COM | 01626L105 | $44,517 | 1,610,000 | SOLE | |||
| Horizon Therapeutics Public Ltd Co | SHS | G46188101 | $43,825 | 599,110 | SOLE | |||
| Krystal Biotech, Inc. | COM | 501147102 | $41,932 | 698,874 | SOLE | |||
| ChemoCentryx, Inc. | COM | 16383L106 | $40,663 | 656,710 | SOLE | |||
| Global Blood Therapeutics, Inc. | COM | 37890U108 | $39,861 | 920,375 | SOLE | |||
| DBV Technologies S.A. | SPONSORED ADR | 23306J101 | $38,289 | 14,614,264 | SOLE | |||
| Opthea Limited | SPONSORED ADS | 68386J208 | $37,107 | 3,308,705 | SOLE | |||
| Merus N.V. | COM | N5749R100 | $35,717 | 2,037,469 | SOLE | |||
| Alkermes plc | SHS | G01767105 | $30,626 | 1,535,149 | SOLE | |||
| Frequency Therapeutics, Inc. | COM | 35803L108 | $30,200 | 856,507 | SOLE | |||
| Protagonist Therapeutics, Inc. | COM | 74366E102 | $28,954 | 1,436,192 | SOLE | |||
| BioAtla, Inc. | COM | 09077B104 | $28,058 | 825,000 | SOLE | |||
| Reata Pharmaceuticals, Inc. | CL A | 75615P103 | $27,688 | 223,976 | SOLE | |||
| Athira Pharma, Inc. | COM | 04746L104 | $27,618 | 806,367 | SOLE |